Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 3 SUPPL., 2005, Pages

  Akerlund, Anders ^a   Andersson, Morgan ^b   Leflein, Jeffrey ^c   Lildholdt, Torben ^d   Mygind, Niels ^e  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Allergy and Immunology Associates of Ann Arbor PC   (United States)

^d Ear Clinic   (Denmark)

^e LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Clinical trial design; H1 antihistamines; Intermittent rhinitis; Intranasal steroids; LTRAs; Nasal allergen challenge; Nasal polyposis; Pediatric rhinitis; Perennial rhinitis; Persistent rhinitis; Seasonal rhinitis

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; ANTIALLERGIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ASTEMIZOLE; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BENZALKONIUM CHLORIDE; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; FEXOFENADINE; GRASS POLLEN EXTRACT; HISTAMINE H1 RECEPTOR ANTAGONIST; HOUSE DUST ALLERGEN; IPRATROPIUM BROMIDE; KETOCONAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCABASTINE; MOMETASONE FUROATE; MONTELUKAST; PRANLUKAST; TERFENADINE; TRIAMCINOLONE; VASOCONSTRICTOR AGENT;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ATROPHIC RHINITIS; BODY WEIGHT DISORDER; BRONCHUS HYPERREACTIVITY; CARDIOTOXICITY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DANDER; DERMATOPHAGOIDES; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MONITORING; DRUG SCREENING; DRUG SPECIFICITY; DRY NOSE; EFFECTOR CELL; ENDOSCOPY; ENVIRONMENTAL EXPOSURE; EPISTAXIS; EYE IRRITATION; FREQUENCY ANALYSIS; HEALTH EDUCATION; HUMAN; INFLAMMATORY CELL; LABORATORY; LAVAGE; LIFESTYLE; LUNG FUNCTION; MEDICAL ASSESSMENT; NONHUMAN; NOSE MUCOSA; NOSE POLYP; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT SATISFACTION; POLLEN; POPULATION; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; RHINOMETRY; RHINORRHEA; SAMPLE SIZE; SEASON; SELF REPORT; SENSITIVITY ANALYSIS; SENSITIZATION; SIDE EFFECT; SMELLING; STANDARD; STATISTICAL ANALYSIS; SYMPTOM; THEORY; VALIDATION PROCESS; WEATHER; WEIGHT GAIN; XEROSTOMIA;

EID: 14644422230     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.12.016     Document Type: Article

References (230)

1. J. Bousquet, P. Van Cauwenberge, and N. Khaltaev Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 108 suppl 5 2001 S147 S334
2. G. D'Amato, A. Ruffilli, G. Sacerdoti, and S. Bonini Parietaria pollinosis: a review Allergy 47 1992 443 449
3. International consensus report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group Allergy 49 suppl 19 1994 1 34
4. P. van Cauwenberge, C. Bachert, G. Passalacqua, J. Bousquet, G.W. Canonica, and S.R. Durham Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology Allergy 55 2000 116 134
5. R.A. Settipane, and P. Lieberman Update on nonallergic rhinitis Ann Allergy Asthma Immunol 86 2001 494 507
6. P.H. Howarth, M.A. Stern, L. Roi, R. Reynolds, and J. Bousquet Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis J Allergy Clin Immunol 104 1999 927 933
7. R.B. Berkowitz, D.I. Bernstein, C. LaForce, A.J. Pedinoff, A.R. Rooklin, and C.R. Damaraju Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis Allergy 54 1999 64 69
8. R.N. Enberg, and D.R. Ownby Peak nasal inspiratory flow and Wright peak flow: a comparison of their reproducibility Ann Allergy 67 1991 371 374
9. M. Bende, T. Carrillo, I. Vona, M.G. da Castel-Branco, and L. Arheden A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis Ann Allergy Asthma Immunol 88 2002 617 623
10. M.A. Stern, R. Dahl, L.P. Nielsen, B. Pedersen, and C. Schrewelius A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis Am J Rhinol 11 1997 323 330
11. P. Creticos, P. Fireman, G. Settipane, D. Bernstein, T. Casale, and H. Schwartz Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group Allergy Asthma Proc 19 1998 285 294
12. E.O. Meltzer Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis Ann Allergy Asthma Immunol 81 1998 128 134
13. J. Day, and T. Carrillo Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis J Allergy Clin Immunol 102 1998 902 908
14. M. Andersson, C. Svensson, C. Persson, A. Akerlund, and L. Greiff Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model Ann Allergy Asthma Immunol 85 2000 279 283
15. C. Ahlstrom-Emanuelsson, C.G. Persson, C. Svensson, M. Andersson, Z. Hosszu, and A. Akerlund Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid Ann Allergy Asthma Immunol 89 2002 159 165
16. C. Ahlstrom-Emanuelsson, M. Andersson, C. Persson, C. Schrewelius, and L. Greiff Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis Clin Exp Allergy 34 2004 731 735
17. J.R. Hebert, K. Nolop, and B.N. Lutsky Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study Allergy 51 1996 569 576
18. J. Del Carpio, L. Kabbash, Y. Turenne, M. Prevost, J. Hebert, and P.M. Bedard Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis J Allergy Clin Immunol 84 1989 741 746
19. G. Karlsson, and H. Rundcrantz Peroral chromones: a new way to treat allergic rhinitis? Acta Otolaryngol Suppl 360 1979 27 29
20. J. Kirkegaard, C. Secher, P. Borum, and N. Mygind Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chlorpheniramine maleate: demonstration of topical effect Br J Dis Chest 77 1983 113 122
21. M.J. Schumacher, K.A. Cota, and L.M. Taussig Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma J Allergy Clin Immunol 78 1 Pt 1 1986 30 35
22. I. Erjefalt, and C.G. Persson On the use of absorbing discs to sample mucosal surface liquids Clin Exp Allergy 20 1990 193 197
23. R.M. Naclerio, H.L. Meier, A. Kagey-Sobotka, N.F. Adkinson Jr., D.A. Meyers, and P.S. Norman Mediator release after nasal airway challenge with allergen Am Rev Respir Dis 128 1983 597 602
24. J.T. Connell Quantitative intranasal pollen challenge, II: effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane J Allergy 41 1968 123 139
25. L. Greiff, U. Pipkorn, U. Alkner, and C.G. Persson The "nasal pool" device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions Clin Exp Allergy 20 1990 253 259
26. L. Greiff, P. Meyer, C. Svensson, C.G. Persson, and M. Andersson The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses Pediatr Allergy Immunol 8 1997 137 142
27. K. Aas, A. Backman, L. Belin, and B. Weeke Standardization of allergen extracts with appropriate methods: the combined use of skin prick testing and radio-allergosorbent tests Allergy 33 1978 130 137
28. D. Wang, J. Smitz, S. Waterschoot, and P. Clement An approach to the understanding of the nasal early-phase reaction induced by nasal allergen challenge Allergy 52 1997 162 167
29. M. Andersson, L. Greiff, C. Svensson, and C. Persson Various methods for testing nasal responses in vivo: a critical review Acta Otolaryngol 115 1995 705 713
30. M. Andersson, H. Nolte, C. Baumgarten, and U. Pipkorn Suppressive effect of loratadine on allergen-induced histamine release in the nose Allergy 46 1991 540 546
31. T. Numata, A. Konno, T. Yamakoshi, T. Hanazawa, N. Terada, and H. Nagata Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy Ann Otol Rhinol Laryngol 108 1999 467 473
32. U. Pipkorn, D. Proud, L.M. Lichtenstein, A. Kagey-Sobotka, P.S. Norman, and R.M. Naclerio Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids N Engl J Med 316 1987 1506 1510
33. M. Andersson, P. Andersson, and U. Pipkorn Allergen-induced specific and non-specific nasal reactions: reciprocal relationship and inhibition by topical glucocorticosteroids Acta Otolaryngol 107 1989 270 277
34. A.M. Wilson, E.J. Sims, L.C. Orr, F. Robb, and B.J. Lipworth An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge Br J Clin Pharmacol 55 2003 354 359
35. D.K. Lee, C.M. Jackson, P.C. Soutar, T.C. Fardon, and B.J. Lipworth Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis Br J Clin Pharmacol 57 2004 714 719
36. H. Klementsson, N. Lindqvist, M. Andersson, and U. Pipkorn Effect of a single dose of a topical glucocorticoid and a cyclo-oxygenase inhibitor on allergen-induced changes in nasal reactivity Allergy 45 1990 604 611
37. R.M. Naclerio, D. Bartenfelder, D. Proud, A.G. Togias, D.A. Meyers, and A. Kagey-Sobotka Theophylline reduces histamine release during pollen-induced rhinitis J Allergy Clin Immunol 78 1986 874 876
38. H. Booij-Noord, K. de Vries, H.J. Sluiter, and N.G. Orie Late bronchial obstructive reaction to experimental inhalation of house dust extract Clin Allergy 2 1972 43 61
39. R. Dahl Early and late-phase reactions in the bronchi and nose N. Mygind U. Pipkorn R. Dahl Rhinitis and asthma 1990 Munksgaard Copenhagen 203 212
40. M. Andersson, J. Rimmer, C. Salome, L. Greiff, and C. Persson Dual symptomatic and exudative nasal responses are not characteristics of perennial allergic rhinitis Acta Otolaryngol 121 2001 407 413
41. Z. Pelikan Late and delayed responses of the nasal mucosa to allergen challenge Ann Allergy 41 1978 37 47
42. U. Pipkorn, D. Proud, L.M. Lichtenstein, R.P. Schleimer, S.P. Peters, and N.F. Adkinson Jr. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge J Clin Invest 80 1987 957 961
43. H. Gronborg, H. Bisgaard, F. Romeling, and N. Mygind Early and late nasal symptom response to allergen challenge: the effect of pretreatment with a glucocorticosteroid spray Allergy 48 1993 87 93
44. P.L. Paggiaro, F.L. Dente, M.C. Morelli, L. Bancalari, A. Di Franco, and D. Giannini Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics Am J Respir Crit Care Med 149 1994 1447 1451
45. A. Miadonna, N. Milazzo, S. Gibelli, C. Salmaso, M. Lorini, and A. Tedeschi Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours Clin Exp Allergy 29 1999 941 949
46. M. Linden, C. Svensson, E. Andersson, M. Andersson, L. Greiff, and C.G. Persson Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5 Am J Respir Crit Care Med 162 2000 1705 1708
47. R. Bascom, M. Wachs, R.M. Naclerio, U. Pipkorn, S.J. Galli, and L.M. Lichtenstein Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment J Allergy Clin Immunol 81 1988 580 589
48. J.T. Connell Quantitative intranasal pollen challenges, 3: the priming effect in allergic rhinitis J Allergy 43 1969 33 44
49. M. Andersson, B. von Kogerer, P. Andersson, and U. Pipkorn Allergen-induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction Allergy 42 1987 631 637
50. H.J. Davies Exposure of hay fever subjects to an indoor environmental grass pollen challenge system Clin Allergy 15 1985 419 427
51. K. Horak, and S. Jager The Vienna challenge chamber (VCC) - a new method for allergen exposition tests Wien Klin Wochenschr 99 1987 509 510
52. J.H. Day, M.P. Briscoe, R.H. Clark, A.K. Ellis, and P. Gervais Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis Ann Allergy Asthma Immunol 79 1997 163 172
53. S.M. Ronborg, H. Mosbech, C.R. Johnsen, and L.K. Poulsen Exposure chamber for allergen challenge: the development and validation of a new concept Allergy 51 1996 82 88
54. R.A. Wood, and P.A. Eggleston The effects of intranasal steroids on nasal and pulmonary responses to cat exposure Am J Respir Crit Care Med 151 1995 315 320
55. J.H. Day, M. Briscoe, and M.D. Widlitz Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit J Allergy Clin Immunol 101 1998 638 645
56. J.H. Day, D.L. Buckeridge, R.H. Clark, M.P. Briscoe, and R. Phillips A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis J Allergy Clin Immunol 97 1996 1050 1057
57. J.H. Day, M.P. Briscoe, E. Rafeiro, A.K. Ellis, E. Pettersson, and A. Akerlund Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model J Allergy Clin Immunol 105 2000 489 494
58. J.T. Connell A novel method to assess antihistamine and decongestant efficacy Ann Allergy 42 1979 278 285
59. E.O. Meltzer, J.M. Weiler, and M.D. Widlitz Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis J Allergy Clin Immunol 97 1996 617 626
60. J.W. Georgitis, E.O. Meltzer, M. Kaliner, J. Weiler, and R. Berkowitz Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge Ann Allergy Asthma Immunol 84 2000 451 459
61. L. Nielsen, C.R. Johnsen, C. Bindslev-Jensen, and L.K. Poulsen Efficacy of acrivastine in the treatment of allergic rhinitis during natural pollen exposure: onset of action Allergy 49 1994 630 636
62. A.L. Donnelly, M. Glass, M.C. Minkwitz, and T.B. Casale The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis Am J Respir Crit Care Med 151 1995 1734 1739
63. U. Pipkorn, G. Karlsson, and L. Enerback Nasal mucosal response to repeated challenges with pollen allergen Am Rev Respir Dis 140 1989 729 736
64. C.H. Blackey Experimental researches on the causes and nature of catarrhus aestivus (hay fever or hay asthma) 1873 Bailliere, Tindall and Cox London
65. T. Godthelp, W.J. Fokkens, A. Kleinjan, A.F. Holm, P.G. Mulder, and E.P. Prens Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation Clin Exp Allergy 26 1996 677 688
66. T. Godthelp, A.F. Holm, W.J. Fokkens, P. Doornenbal, P.G. Mulder, and E.C. Hoefsmit Dynamics of nasal eosinophils in response to a nonnatural allergen challenge in patients with allergic rhinitis and control subjects: a biopsy and brush study J Allergy Clin Immunol 97 1996 800 811
67. J.S. Erjefalt, L. Greiff, M. Andersson, E. Matsson, H. Petersen, and M. Linden Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways Am J Respir Crit Care Med 160 1999 304 312
68. M.S. Dykewicz, and S. Fineman Executive summary of joint task force practice parameters on diagnosis and management of rhinitis Ann Allergy Asthma Immunol 81 1998 463 468
69. Katz-Chobert B. Allergic rhinitis in children is often overlooked and undertreated: expert panel recommends improved detection and treatment to reduce effects on children's health and well-being, 1998. Available at: http://www.kidsource.com/kidsource/content5/allergic.rhinitis.html. Accessed November 12, 2004
70. M.S. Dykewicz, S. Fineman, D.P. Skoner, R. Nicklas, R. Lee, and J. Blessing-Moore Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology Ann Allergy Asthma Immunol 81 1998 478 518
71. R.A. Nathan, E.O. Meltzer, J.C. Selner, and W. Storms Prevalence of allergic rhinitis in the United States J Allergy Clin Immunol 99 1997 S808 S814
72. A.L. Wright, C.J. Holberg, F.D. Martinez, M. Halonen, W. Morgan, and L.M. Taussig Epidemiology of physician-diagnosed allergic rhinitis in childhood Pediatrics 94 1994 895 901
73. P. Cullinan, S.J. MacNeill, J.M. Harris, S. Moffat, C. White, and P. Mills Early allergen exposure, skin prick responses, and atopic wheeze at age 5 in English children: a cohort study Thorax 59 2004 855 861
74. G.S. Rachelefsky National guidelines needed to manage rhinitis and prevent complications Ann Allergy Asthma Immunol 82 1999 296 305
75. E.F. Juniper, G.H. Guyatt, and J. Dolovich Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials J Allergy Clin Immunol 93 1994 413 423
76. E.F. Juniper Measuring health-related quality of life in rhinitis J Allergy Clin Immunol 99 1997 S742 S749
77. E.F. Juniper, W.C. Howland, N.B. Roberts, A.K. Thompson, and D.R. King Measuring quality of life in children with rhinoconjunctivitis J Allergy Clin Immunol 101 1998 163 170
78. E.F. Vuurman, L.M. van Veggel, M.M. Uiterwijk, D. Leutner, and J.F. O'Hanlon Seasonal allergic rhinitis and antihistamine effects on children's learning Ann Allergy 71 1993 121 126
79. E.F. Vuurman, L.M. van Veggel, R.L. Sanders, N.D. Muntjewerff, and J.F. O'Hanlon Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis Ann Allergy Asthma Immunol 76 1996 247 252
80. P.S. Marshall, C. O'Hara, and P. Steinberg Effects of seasonal allergic rhinitis on selected cognitive abilities Ann Allergy Asthma Immunol 84 2000 403 410
81. S.R. Nimmagadda, and R. Evans 3rd. Allergy: etiology and epidemiology Pediatr Rev 20 1999 111 115
82. P.W. Newacheck, and J.J. Stoddard Prevalence and impact of multiple childhood chronic illnesses J Pediatr 124 1994 40 48
83. P. Verdiani, S. Di Carlo, and A. Baronti Different prevalence and degree of nonspecific bronchial hyperreactivity between seasonal and perennial rhinitis J Allergy Clin Immunol 86 1990 576 582
84. S.S. Braman, A.A. Barrows, B.A. DeCotiis, G.A. Settipane, and W.M. Corrao Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma Chest 91 1987 671 674
85. R.G. Townley, U.Y. Ryo, B.M. Kolotkin, and B. Kang Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects J Allergy Clin Immunol 56 1975 429 442
86. G.S. Rachelefsky, S.C. Siegel, R.M. Katz, S.L. Spector, and A.S. Rohr Chronic sinusitis in children J Allergy Clin Immunol 87 1991 219
87. G.G. Shapiro, F.S. Virant, C.T. Furukawa, W.E. Pierson, and C.W. Bierman Immunologic defects in patients with refractory sinusitis Pediatrics 87 1991 311 316
88. G.S. Rachelefsky, M. Goldberg, R.M. Katz, G. Boris, M.T. Gyepes, and M.J. Shapiro Sinus disease in children with respiratory allergy J Allergy Clin Immunol 61 1978 310 314
89. J.M. Bernstein, J. Lee, K. Conboy, E. Ellis, and P. Li Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion Otolaryngol Head Neck Surg 93 1985 611 615
90. D.P. Skoner Complications of allergic rhinitis J Allergy Clin Immunol 105 2000 S605 S609
91. D. Bresolin, P.A. Shapiro, G.G. Shapiro, M.K. Chapko, and S. Dassel Mouth breathing in allergic children: its relationship to dentofacial development Am J Orthod 83 1983 334 340
92. G.M. Trask, G.G. Shapiro, and P.A. Shapiro The effects of perennial allergic rhinitis on dental and skeletal development: a comparison of sibling pairs Am J Orthod Dentofacial Orthop 92 1987 286 293
93. S.C. Siegel Rhinitis in children N. Mygind R.M. Naclerio Allergic and non-allergic rhinitis: clinical aspects 1993 Munksgaard Copenhagen 174 183
94. E.O. Meltzer, R.S. Zeiger, M. Schatz, and A.A. Jalowayski Chronic rhinitis in infants and children: etiologic, diagnostic, and therapeutic considerations Pediatr Clin North Am 30 1983 847 871
95. P. Fireman Therapeutic approaches to allergic rhinitis: treating the child J Allergy Clin Immunol 105 2000 S616 S621
96. L. Smith Special considerations for the child with airway disease J Allergy Clin Immunol 101 1998 S370 S372
97. J.L. Menardo, J. Bousquet, M. Rodiere, J. Astruc, and F.B. Michel Skin test reactivity in infancy J Allergy Clin Immunol 75 1985 646 651
98. N. Mygind Nasal polyposis J Allergy Clin Immunol 86 1990 827 829
99. P. Keith, and J. Dolovich Allergy and nasal polyposis N. Mygind T. Lildholt Nasal polyposis 1997 Munksgaard Copenhagen 68 77
100. A.B. Drake-Lee Medical treatment of nasal polyps Rhinology 32 1994 1 4
101. T. Lildholt, R. Dahl, and N. Mygind Effect of corticosteroids on nasal polyps N. Mygind T Lildholt Nasal polyposis 1997 Munksgaard Copenhagen
102. V.J. Lund, J. Flood, A.P. Sykes, and D.H. Richards Effect of fluticasone in severe polyposis Arch Otolaryngol Head Neck Surg 124 1998 513 518
103. Y.G. Amar, S. Frenkiel, and S.E. Sobol Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad J Otolaryngol 29 2000 7 12
104. R. Jankowski, D. Pigret, and F. Decroocq Comparison of functional results after ethmoidectomy and nasalization for diffuse and severe nasal polyposis Acta Otolaryngol 117 1997 601 608
105. R.M. Naclerio, and I.S. MacKay Guidelines for the management of nasal polyposis N. Mygind T. Lildholt Nasal polyposis 1997 Munksgaard Copenhagen 177 180
106. K. Holmberg, and G. Karlsson Nasal polyps: surgery of pharmacological intervention? Eur Respir Rev 20 1994 260 265
107. V.J. Lund Diagnosis and treatment of nasal polyps BMJ 311 1995 1411 1414
108. M. Weschta, D. Rimek, M. Formanek, D. Polzehl, A. Podbielski, and H. Riechelmann Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial J Allergy Clin Immunol 113 2004 1122 1128
109. S.M. Ragab, V.J. Lund, and G. Scadding Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial Laryngoscope 114 2004 923 930
110. M.D. Dijkstra, F.A. Ebbens, R.M. Poublon, and W.J. Fokkens Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery Clin Exp Allergy 34 2004 1395 1400
111. P. Bonfils, J.M. Nores, P. Halimi, and P. Avan Medical treatment of stage I nasal polyposis over a 3-year follow-up period ORL J Otorhinolaryngol Relat Spec 66 2004 27 34
112. R. Jankowski, and C. Bodino Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization) Rhinology 41 2003 220 230
113. K. Larsen The clinical relationship of nasal polyps to asthma G.A. Settipane V.J. Lund J.M. Bernstein M. Tos Nasal polyps: Epidemiology, pathogenesis and treatment 1997 OceanSide Providence (RI)
114. G.A. Settipane, and R.A. Settipane Nasal polyps and aspirin intolerance G.A. Settipane V.J. Lund J.M. Bernstein M. Tos Nasal polyps: epidemiology, pathogenesis and treatment 1997 OceanSide Providence (RI)
115. J.B. Watelet, B. Annicq, P. van Cauwenberge, and C. Bachert Objective outcome after functional endoscopic sinus surgery: prediction factors Laryngoscope 114 2004 1092 1097
116. P.J. Oliverio, M.L. Benson, and S.J. Zinreich Basic sinus imaging and radiological aspects of nasal polyposis G.A. Settipane V.J. Lund J.M. Bernstein M. Tos Nasal polyps: epidemiology, pathogenesis and treatment 1997 OceanSide Providence (RI)
117. C. Bachert, T. van Zele, P. Gevaert, L. De Schrijver, and P. Van Cauwenberge Superantigens and nasal polyps Curr Allergy Asthma Rep 3 2003 523 531
118. J.M. Bernstein, M. Ballow, P.M. Schlievert, G. Rich, C. Allen, and D. Dryja A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis Am J Rhinol 17 2003 321 326
119. C.A. Perez-Novo, M.L. Kowalski, P. Kuna, A. Ptasinska, G. Holtappels, and P. van Cauwenberge Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship Int Arch Allergy Immunol 133 2004 255 260
120. A. Drake-Lee Magical numbers and the treatment of nasal polyps Clin Otolaryngol 21 1996 193 197
121. T. Lildholdt, J. Fogstrup, N. Gammelgaard, B. Kortholm, and C. Ulsoe Surgical versus medical treatment of nasal polyps Acta Otolaryngol 105 1988 140 143
122. T. Lildholdt, H. Rundcrantz, and N. Lindqvist Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide Clin Otolaryngol 20 1995 26 30
123. T. Lildholdt, H. Rundcrantz, M. Bende, and K. Larsen Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment Arch Otolaryngol Head Neck Surg 123 1997 595 600
124. L. Johansson, A. Akerlund, K. Holmberg, I. Melen, P. Stierna, and M. Bende Evaluation of methods for endoscopic staging of nasal polyposis Acta Otolaryngol 120 2000 72 76
125. H. Stammberger Examination and endoscopy of the nose and paranasal sinuses N. Mygind T. Lildholt Nasal polyposis 1997 Munksgaard Copenhagen 120 136
126. G. Rasp, M.F. Kramer, P. Ostertag, and E. Kastenbauer [A new system for the classification of ethmoid polyposis: effect of combined local and systemic steroid therapy] [in German] Laryngorhinootologie 79 2000 266 272
127. L. Frolund, F. Madsen, N. Mygind, N.H. Nielsen, U.G. Svendsen, and B. Weeke Comparison between different techniques for measuring nasal patency in a group of unselected patients Acta Otolaryngol 104 1987 175 179
128. J.W. Fairley, L.H. Durham, and S.R. Ell Correlation of subjective sensation of nasal patency with nasal inspiratory peak flow rate Clin Otolaryngol 18 1993 19 22
129. R.W. Clarke, and A.S. Jones The limitations of peak nasal flow measurement Clin Otolaryngol 19 1994 502 504
130. J. Marais, J.A. Murray, I. Marshall, N. Douglas, and S. Martin Minimal cross-sectional areas, nasal peak flow and patients' satisfaction in septoplasty and inferior turbinectomy Rhinology 32 1994 145 147
131. M.J. Porter, I.G. Williamson, D.H. Kerridge, and A.R. Maw A comparison of the sensitivity of manometric rhinometry, acoustic rhinometry, rhinomanometry and nasal peak flow to detect the decongestant effect of xylometazoline Clin Otolaryngol 21 1996 218 221
132. M. Ahman Nasal peak flow rate records in work related nasal blockage Acta Otolaryngol 112 1992 839 844
133. K. Larsen, and S. Kristensen Peak flow nasal patency indices and self-assessment in septoplasty Clin Otolaryngol 15 1990 327 334
134. J.A. Wihl, and L. Malm Rhinomanometry and nasal peak expiratory and inspiratory flow rate Ann Allergy 61 1988 50 55
135. M. Holmstrom, G.K. Scadding, V.J. Lund, and Y.C. Darby Assessment of nasal obstruction: a comparison between rhinomanometry and nasal inspiratory peak flow Rhinology 28 1990 191 196
136. J. Cote, A. Cartier, J.L. Malo, M. Rouleau, and L.P. Boulet Compliance with peak expiratory flow monitoring in home management of asthma Chest 113 1998 968 972
137. D.A. Deems, R.L. Doty, R.G. Settle, V. Moore-Gillon, P. Shaman, and A.F. Mester Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center Arch Otolaryngol Head Neck Surg 117 1991 519 528
138. R.L. Doty Olfaction N. Mygind T. Lildholdt Nasal polyposis 1997 Munksgaard Copenhagen 153 159
139. L. Klimek, B. Moll, R.G. Amedee, and W.J. Mann Olfactory function after microscopic endonasal surgery in patients with nasal polyps Am J Rhinol 11 1997 251 255
140. V. Moore-Gillon Olfactory and the sense of smell I. Mackay Rhinitis: mechanisms and management 1989 Royal Society of Medicine Services Ltd London 69 79
141. H. Auffermann, G. Gerull, F. Mathe, and D. Mrowinski Olfactory evoked potentials and contingent negative variation simultaneously recorded for diagnosis of smell disorders Ann Otol Rhinol Laryngol 102 1993 6 10
142. W.A. Simpson The method of constant stimuli is efficient Percept Psychophys 44 1988 433 436
143. A. Akerlund, M. Bende, and C. Murphy Olfactory threshold and nasal mucosal changes in experimentally induced common cold Acta Otolaryngol 115 1995 88 92
144. K.W. Delank, and W. Stoll Olfactory function after functional endoscopic sinus surgery for chronic sinusitis Rhinology 36 1998 15 19
145. I. Kenriksdottir, C. Murphy, and M. Bende Olfactory threshold after nasal allergen challenge ORL J Otorhinolaryngol Relat Spec 59 1997 36 38
146. F. Radenne, C. Lamblin, L.M. Vandezande, I. Tillie-Leblond, J. Darras, and A.B. Tonnel Quality of life in nasal polyposis J Allergy Clin Immunol 104 1999 79 84
147. L. Derekoylu, S. Canakcioglu, A. Mamak, M.G. Guvenc, and A. Banitahmaseb [Quality of life assessment with the use of the SF-36 in patients with nasal polyposis: correlations with clinical and laboratory findings] [in Turkish] Kulak Burun Bogaz Ihtis Derg 11 2003 72 79
148. L. Greiff, J.S. Erjefalt, M. Andersson, C. Svensson, and C. Persson Microvascular exudation of plasma and epithelial shedding-restitution processes as causative events in inflammatory airways diseases N. Mygind T. Lildholt Nasal polyposis 1997 Munksgaard Copenhagen 50 60
149. N. Kanai, J. Denburg, M. Jordana, and J. Dolovich Nasal polyp inflammation: effect of topical nasal steroid Am J Respir Crit Care Med 150 1994 1094 1100
150. I. Mackay, and V.J. Lund Imaging and staging N. Mygind T. Lildholdt Nasal polyposis 1997 Munksgaard Copenhagen
151. J. Rowe-Jones, I. Mackay, and I. Colquhoun Charing Cross CT protocol for endoscopic sinus surgery J Laryngol Otol 109 1995 1057 1060
152. C. van Camp, and P.A. Clement Results of oral steroid treatment in nasal polyposis Rhinology 32 1994 5 9
153. P. O'Flynn Acoustic rhinometry: validation of volume changes following intra-nasal polypectomy Clin Otolaryngol 18 1993 423 425
154. O. Elbrond, J.U. Felding, and K.M. Gustavsen Acoustic rhinometry used as a method to monitor the effect of intramuscular injection of steroid in the treatment of nasal polyps J Laryngol Otol 105 1991 178 180
155. P.K. Honig, D.C. Wortham, K. Zamani, D.P. Conner, J.C. Mullin, and L.R. Cantilena Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences JAMA 269 1993 1513 1518
156. N. Mygind, and V. Lund Topical corticosteroid therapy of rhinitis: a review Clin Immunother 5 1996 122 136
157. G. Passalacqua, M. Albano, G.W. Canonica, C. Bachert, P. Van Cauwenberge, and R.J. Davies Inhaled and nasal corticosteroids: safety aspects Allergy 55 2000 16 33
158. W.J. Pichler, T. Klint, M. Blaser, W. Graf, K. Sauter, and S. Weiss Clinical comparison of systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis Allergy 43 1988 87 92
159. P. Sohoel, B.A. Freng, J. Kramer, S. Poppe, R. Rebo, and F.R. Korsrud Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis J Allergy Clin Immunol 92 1993 73 81
160. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. The Livostin Study Group Allergy 48 1993 530 534
161. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team Allergy 49 1994 611 615
162. C.J. Trigg, and R.J. Davies Local antihistamines Clin Exp Allergy 26 1996 1108 1111
163. T.C. Stokes, and G. Feinberg Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis Clin Exp Allergy 23 1993 791 794
164. R. Eccles Nasal airflow and decongestants R.M. Naclerio S.R. Durham N. Mygind Rhinitis: mechanisms and management 1999 Marcel Dekker New York 291 312
165. N. Mygind, P. Borum, F.M. Baroody, and R.M. Naclerio Anticholinergic medication R.M. Naclerio L.H. Durham N. Mygind Rhinitis: mechanisms and management 1999 Marcel Dekker New York 313 334
166. S.P. Newman, F. Moren, and S.W. Clarke Deposition pattern from a nasal pump spray Rhinology 25 1987 77 82
167. A. Toft, J.A. Wihl, J. Toxman, and N. Mygind Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis Clin Allergy 12 1982 391 401
168. H. Hallen, and P. Graf Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers Clin Exp Allergy 25 1995 401 405
169. J.P. Braat, G. Ainge, J.A. Bowles, D.H. Richards, D. Van Riessen, and
170. N. Mygind, and R.M. Naclerio Intranasal corticosteroids R.M. Naclerio L.H. Durham N. Mygind Rhinitis: mechanisms and management 1999 Marcel Dekker New York 221 256
171. V. Lund, D. Aaronson, and J. Bousquet International consensus report on the diagnosis and management of rhinitis Allergy 49 suppl 19 1994 1 34
172. T. Puhakka, M.J. Makela, K. Malmstrom, M. Uhari, J. Savolainen, and E.O. Terho The common cold: effects of intranasal fluticasone propionate treatment J Allergy Clin Immunol 101 1998 726 731
173. M.K. Church Non-H1-receptor effects of antihistamines Clin Exp Allergy 29 suppl 3 1999 39 48
174. G. Di Lorenzo, F. Gervasi, A. Drago, M. Esposito Pellitteri, A. Di Salvo, and D. Cosentino Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics Clin Exp Allergy 29 1999 1367 1377
175. G. Ciprandi, I. Cirillo, A. Vizzaccaro, and M.A. Tosca Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study Clin Exp Allergy 34 2004 958 964
176. G. Ciprandi, M.A. Tosca, M. Milanese, and V. Ricca Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis Allerg Immunol (Paris) 36 2004 237 240
177. D.A. Stempel, and M. Thomas Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines Am J Manag Care 4 1998 89 96
178. J.M. Weiner, M.J. Abramson, and R.M. Puy Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials BMJ 317 1998 1624 1629
179. E. Bronsky, P. Boggs, S. Findlay, S. Gawchik, J. Georgitis, and H. Mansmann Comparative efficacy and safety of a once-daily loratadine- pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis J Allergy Clin Immunol 96 1995 139 147
180. G.L. Sussman, J. Mason, D. Compton, J. Stewart, and N. Ricard The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis J Allergy Clin Immunol 104 1999 100 106
181. M. Grosclaude, K. Mees, M.E. Pinelli, M. Lucas, and H. Van de Venne Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis Rhinology 35 1997 67 73
182. S. Borum, K. Nielsen, H. Bisgaard, and N. Mygind Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine Rhinology 36 1998 153 155
183. S.M. Tarlo, D.W. Cockcroft, J. Dolovich, and F.E. Hargreave Beclomethasone dipropionate aerosol in perennial rhinitis J Allergy Clin Immunol 59 1977 232 236
184. P. Borum, H. Gronborg, and N. Mygind Seasonal allergic rhinitis and depot injection of a corticosteroid: evaluation of the efficacy of medication early and late in the season based on detailed symptom recording Allergy 42 1987 26 32
185. N. Mygind Local effect of intranasal beclomethasone dipropionate aerosol in hay fever BMJ 4 1973 464 466
186. N. Mygind, C.B. Pedersen, S. Prytz, and H. Sorensen Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol Clin Allergy 5 1975 159 164
187. J. Rinne, M. Simola, H. Malmberg, and T. Haahtela Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome J Allergy Clin Immunol 109 2002 426 432
188. T. Haahtela, M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, and K. Lehtonen Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma N Engl J Med 325 1991 388 392
189. R.M. Naclerio, N.F. Adkinson Jr., P.S. Creticos, F.M. Baroody, R.G. Hamilton, and P.S. Norman Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies J Allergy Clin Immunol 92 1993 717 721
190. M. Tos, F. Svendstrup, H. Arndal, S. Orntoft, J. Jakobsen, and P. Borum Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps Am J Rhinol 12 1998 183 189
191. N. Mygind, R. Dahl, L.P. Nielsen, O. Hilberg, and T. Bjerke Effect of corticosteroids on nasal blockage in rhinitis measured by objective methods Allergy 52 suppl 40 1997 39 44
192. E.O. Meltzer, H.A. Orgel, P.R. Rogenes, and E.A. Field Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate J Allergy Clin Immunol 94 1994 708 715
193. H. Klementsson, C. Svensson, M. Andersson, P. Venge, U. Pipkorn, and C.G. Persson Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season Clin Exp Allergy 21 1991 705 710
194. L. Malm, J.A. Wihl, C.J. Lamm, and N. Lindqvist Reduction of metacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis Allergy 36 1981 209 214
195. J.M. Studham, F. O'Connell, J. Henderson, V.E. Thomas, R.W. Fuller, and N.B. Pride Effect of topical beclomethasone on histamine-induced increases in nasal airflow resistance and secretion in perennial rhinitis Clin Otolaryngol 18 1993 285 290
196. M.A. Birchall, J.C. Henderson, J.M. Studham, I. Phillips, N.B. Pride, and R.W. Fuller The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis Clin Otolaryngol 20 1995 204 210
197. J.M. Henriksen, and A. Wenzel Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma Am Rev Respir Dis 130 1984 1014 1018
198. C.E. Reed, J.P. Marcoux, and P.W. Welsh Effects of topical nasal treatment on asthma symptoms J Allergy Clin Immunol 81 1988 1042 1047
199. D.P. Skoner, G.S. Rachelefsky, E.O. Meltzer, P. Chervinsky, R.M. Morris, and J.M. Seltzer Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate Pediatrics 105 2000 E23
200. N. Mygind, L.C. Laursen, and M. Dahl Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy Allergy 55 2000 11 15
201. F.E. Simons, and K.J. Simons Clinical pharmacology of new histamine H1 receptor antagonists Clin Pharmacokinet 36 1999 329 352
202. R. Jankowski, M. Wagenmann, F.M. Baroody, and R. Naclerio Effect of terfenadine on nasal provocation Int Arch Allergy Immunol 101 1993 311 317
203. O. Hilberg, L.F. Grymer, and O.F. Pedersen Nasal histamine challenge in nonallergic and allergic subjects evaluated by acoustic rhinometry Allergy 50 1995 166 173
204. K.E. Thomas, S. Ollier, H. Ferguson, and R.J. Davies The effect of intranasal azelastine, Rhinolast, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen Clin Exp Allergy 22 1992 642 647
205. K. Horak, S. Jager, J. Toth, U. Berger, and E. Nimberger Azelastine in pollen-induced allergic rhinitis Drug Invest 7 1994 34 40
206. E.A. Bronsky, R.J. Dockhorn, E.O. Meltzer, G. Shapiro, H. Boltansky, and C. LaForce Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis J Allergy Clin Immunol 97 1996 915 921
207. G. Jordana, J. Dolovich, M.P. Briscoe, J.H. Day, M.A. Drouin, and M. Gold Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis J Allergy Clin Immunol 97 1996 588 595
208. A. Pelucchi, A. Chiapparino, B. Mastropasqua, L. Marazzini, A. Hernandez, and A. Foresi Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens J Allergy Clin Immunol 95 1995 515 523
209. T. de Graaf-in 't Veld, I.M. Garrelds, A.W. van Toorenenbergen, P.G. Mulder, R. Gerth van Wijk, and J.P. Boegheim Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis Ann Allergy Asthma Immunol 75 1995 261 266
210. Y.G. Yap, and A.J. Camm The current cardiac safety situation with antihistamines Clin Exp Allergy 29 suppl 1 1999 15 24
211. C.J. Falliers, M.L. Brandon, E. Buchman, J.T. Connell, R. Dockhorn, and P.T. Leese Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis Ann Allergy 66 1991 257 262
212. J.A. Wihl, B.N. Petersen, L.N. Petersen, G. Gundersen, K. Bresson, and N. Mygind Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis J Allergy Clin Immunol 75 1985 720 727
213. P.H. Howarth Leukotrienes in rhinitis Am J Respir Crit Care Med 161 2000 S133 S136
214. N. Mygind, R. Dahl, and H. Bisgaard Leukotrienes, leukotriene receptor antagonists, and rhinitis Allergy 55 2000 421 424
215. B. Dahlen, E. Nizankowska, A. Szczeklik, O. Zetterstrom, G. Bochenek, and M. Kumlin Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics Am J Respir Crit Care Med 157 1998 1187 1194
216. E.O. Meltzer, K. Malmstrom, S. Lu, B.M. Prenner, L.X. Wei, and S.F. Weinstein Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial J Allergy Clin Immunol 105 2000 917 922
217. G. Philip, K. Malmstrom, F.C. Hampel, S.F. Weinstein, C.F. LaForce, and P.H. Ratner Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring Clin Exp Allergy 32 2002 1020 1028
218. J. van Adelsberg, G. Philip, C.F. LaForce, S.F. Weinstein, J. Menten, and M.P. Malice Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis Ann Allergy Asthma Immunol 90 2003 214 222
219. J. van Adelsberg, G. Philip, A.J. Pedinoff, E.O. Meltzer, P.H. Ratner, and J. Menten Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period Allergy 58 2003 1268 1276
220. P. Chervinsky, G. Philip, M.P. Malice, J. Bardelas, A. Nayak, and J.L. Marchal Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies Ann Allergy Asthma Immunol 92 2004 367 373
221. C. Svensson, M. Andersson, L. Greiff, L.O. Blychert, and C.G. Persson Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis Allergy 53 1998 367 374
222. P.H. Ratner, W.C. Howland 3rd, R. Arastu, E.E. Philpot, K.C. Klein, and C.A. Baidoo Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast Ann Allergy Asthma Immunol 90 2003 536 542
223. T. Ueda, S. Takeno, K. Furukido, K. Hirakawa, and K. Yajin Leukotriene receptor antagonist pranlukast suppresses eosinophil infiltration and cytokine production in human nasal mucosa of perennial allergic rhinitis Ann Otol Rhinol Laryngol 112 2003 955 961
224. H. Gronborg, P. Borum, and N. Mygind Histamine and methacholine do not increase nasal reactivity Clin Allergy 16 1986 597 602
225. T. Pullerits, L. Praks, V. Ristioja, and J. Lotvall Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis J Allergy Clin Immunol 109 2002 949 955
226. G. Di Lorenzo, M.L. Pacor, M.E. Pellitteri, G. Morici, A. Di Gregoli, and C. Lo Bianco Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis Clin Exp Allergy 34 2004 259 267
227. E.F. Juniper, P.A. Kline, F.E. Hargreave, and J. Dolovich Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis J Allergy Clin Immunol 83 1989 627 633
228. C. Benincasa, and R.S. Lloyd Evaluation of fluticasone propionate aqueous nasal spray taken alone or in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis Drug Invest 8 1994 225 233
229. R.J. Simpson Budesonide and terfenadine, separately and in combination, in the treatment of hay fever Ann Allergy 73 1994 497 502
230. P.H. Ratner, J.H. van Bavel, B.G. Martin, F.C. Hampel Jr., W.C. Howland 3rd, and P.R. Rogenes A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis J Fam Pract 47 1998 118 125